[{"from": "human", "value": "Provide a brief overview of this molecule. [C][C][C][=Branch1][C][=O][O][C][C][=Branch1][C][=O][C@][Branch2][Ring2][Branch1][C][C][C@@H1][C@@][Ring1][Branch1][Branch2][Ring1][O][C][C@@H1][Branch2][Ring1][Branch1][C@H1][C@H1][Ring1][=Branch1][C][C][C][=C][C][=Branch1][C][=O][C][=C][C@][Ring1][O][Ring1][#Branch1][C][O][C][O][C][=Branch1][C][=O][O][C][C]"}, {"from": "gpt", "value": "The molecule is a relatively new topical corticosteroid drug that displays a similar potency as [hydrocortisone]. It is used in the treatment of inflammatory skin diseases, such as atopic dermatitis. It has a favorable benefit-risk ratio, with an inflammatory action similar to that of a medium potency corticosteroid, but with a low potential to cause skin atrophy. The anti-inflammation action of corticosteroids is associated with the inhibition of the interleukin 1-alpha cytokine within keratinocytes. IL-1a is also found in fibroblasts, where it is responsible for proliferation, collagenase induction and IL-6 synthesis, which are related to skin thickness."}]